BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24510338)

  • 21. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
    Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
    Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.
    de Jong D; Rosenwald A; Chhanabhai M; Gaulard P; Klapper W; Lee A; Sander B; Thorns C; Campo E; Molina T; Norton A; Hagenbeek A; Horning S; Lister A; Raemaekers J; Gascoyne RD; Salles G; Weller E;
    J Clin Oncol; 2007 Mar; 25(7):805-12. PubMed ID: 17327602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma.
    Wahlin BE; Sander B; Christensson B; Kimby E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):388-97. PubMed ID: 17255259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell inflamed tumor microenvironment predicts favorable prognosis in primary testicular lymphoma.
    Leivonen SK; Pollari M; Brück O; Pellinen T; Autio M; Karjalainen-Lindsberg ML; Mannisto S; Kellokumpu-Lehtinen PL; Kallioniemi O; Mustjoki S; Leppä S
    Haematologica; 2019 Feb; 104(2):338-346. PubMed ID: 30237271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.
    Alvaro T; Lejeune M; Salvadó MT; Lopez C; Jaén J; Bosch R; Pons LE
    J Clin Oncol; 2006 Dec; 24(34):5350-7. PubMed ID: 17135637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer-assisted quantification of CD3+ T cells in follicular lymphoma.
    Abas FS; Shana'ah A; Christian B; Hasserjian R; Louissaint A; Pennell M; Sahiner B; Chen W; Niazi MKK; Lozanski G; Gurcan M
    Cytometry A; 2017 Jun; 91(6):609-621. PubMed ID: 28110507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical validation of quantitative immunohistochemical assays of tumor infiltrating lymphocyte biomarkers.
    Singh U; Cui Y; Dimaano N; Mehta S; Pruitt SK; Yearley J; Laterza OF; Juco JW; Dogdas B
    Biotech Histochem; 2018; 93(6):411-423. PubMed ID: 29863904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancer.
    Iurchenko NP; Glushchenko NM; Buchynska LG
    Exp Oncol; 2014 Dec; 36(4):262-6. PubMed ID: 25537221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation.
    Kiaii S; Clear AJ; Ramsay AG; Davies D; Sangaralingam A; Lee A; Calaminici M; Neuberg DS; Gribben JG
    J Clin Oncol; 2013 Jul; 31(21):2654-61. PubMed ID: 23775959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial.
    Budau L; Wilhelm C; Moll R; Jäkel J; Hirt C; Dölken G; Maschmeyer G; Neubauer E; Strauch K; Burchert A; Herold M; Neubauer A
    J Cancer Res Clin Oncol; 2019 Aug; 145(8):2149-2156. PubMed ID: 31273513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The composition of the microenvironment in follicular lymphoma is associated with the stage of the disease.
    Koch K; Hoster E; Unterhalt M; Ott G; Rosenwald A; Hansmann ML; Engelhard M; Hiddemann W; Klapper W
    Hum Pathol; 2012 Dec; 43(12):2274-81. PubMed ID: 22795355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of flow cytometry in subtyping composite and sequential lymphoma.
    Siebert JD; Mulvaney DA; Vukov AM; Knost JA; King DE; Craig FE
    J Clin Lab Anal; 1999; 13(5):199-204. PubMed ID: 10494126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
    Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
    PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.
    Hagos YB; Akarca AU; Ramsay A; Rossi RL; Pomplun S; Ngai V; Moioli A; Gianatti A; Mcnamara C; Rambaldi A; Quezada SA; Linch D; Gritti G; Yuan Y; Marafioti T
    Hematol Oncol; 2022 Oct; 40(4):541-553. PubMed ID: 35451108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
    Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
    Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
    Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
    BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.